UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_______________________

FORM 10-Q
_______________________
(Mark One)
þQuarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2012March 31, 2013

or
 
o¨Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from___________ to ____________
      
Commission file number 000-52622

GREEN PLANET BIOENGINEERING CO., LTD.
(Exact Name of Registrant as Specified in its charter)
 
Delaware 37-1532842
(State or other jurisdiction of incorporation or organization) (I.R.S. (I.R.S. Employer Identification No.)
19950 West Country Club Drive,
Suite 100,Aventura, Florida
 33180
(AddressSuite 100,Aventura, Florida 33180
 (Address of principal executive offices) (Zip Code)
 
(305) 328-8662
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ¨    No ¨

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer
 o
Accelerated filer
 o
Non-accelerated filer
 o
Smaller reporting company
 þx

(Do not check if a smaller company) 
(Do not check if a smaller company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes þ  No  ¨

 
The number of shares of common stock outstanding as of November 8, 2012May 10, 2013 was 20,006,402.
 
 
 
 
TABLE OF CONTENTS
 
  Page Number
PART I  Page NumberFINANCIAL INFORMATION 
   
PART I  FINANCIAL INFORMATION
Item 1.Financial Statements41
   
 Balance Sheets as of September 30, 2012March 31, 2013 (Unaudited) and December 31, 2011 (Audited)201241
 
Statements of Income for the Three and Nine Months Ended September 30,March 31, 2013 and 2012 and 2011 (Unaudited)5
2
 Statements of Cash Flows for the NineThree Months Ended September 30,March 31, 2013 and 2012 and 2011 (Unaudited)6
3
 Notes to the Financial Statements (Unaudited)74
   
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations97
   
Item 3.Quantitative and Qualitative Disclosures about Market Risk108
   
Item 4.Controls and Procedures8
  10
PART IIOTHER INFORMATION 
   
PART IIOTHER INFORMATION
Item 1.Legal Proceedings119
   
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds119
   
Item 3.Defaults upon Senior Securities119
   
Item 4.Reserved119
   
Item 5.Other Information119
   
Item 6.Exhibits119
   
 
SIGNATURES1210
 
2i
 

INTERIM FINANCIAL STATEMENTS

The unaudited interim unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with the instructions under Regulation S-X of the Securities and Exchange Commission (“SEC”) Form 10-Q. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended December 31, 2011.2012.

The financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s financial position as of the period reporting date, and the results of its operations and cash flows for the reportingfiscal period end. The results of operations for the reportingfiscal period end are not necessarily indicative of the results to be expected for future quarters or the full fiscal year.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934.  These statements involve risks and uncertainties, including, among other things, statements regarding our business strategy, future revenues and anticipated costs and expenses.  Such forward-looking statements include, among others, those statements including the words “expects,” “anticipates,” “intends,” “believes,” “may,” “will,” “should,” “could,” “plans,” “estimates,” and similar language or negative of such terms.  Our actual results may differ significantly from those projected in the forward-looking statements.  Factors that might cause or contribute to such differences include, but are not limited to, those discussed in Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”  You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report.  Although we believe that the expectations reflected in the forward-looking statements are reasonable, we do not know whether we can achieve positive future results, levels of activity, performance, or goals.  Actual events or results may differ materially.  We undertake no obligation to publicly release any revisions to the   forward-looking statements or reflect events or circumstances taking place after the date of this document.


 
3ii
 
 
PART IFINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS
 
Green Planet Bioengineering Co., Ltd.
Green Planet Bioengineering Co., Ltd.
Balance Sheets
Balance Sheets
(Stated in US Dollars)
 
  September 30,  December 31, 
  2012  2011 
  (Unaudited)    
       
ASSETS      
Current assets
      
Cash and cash equivalents
 $-  $668 
Prepaid expenses
  1,425   - 
         
TOTAL ASSETS
 $1,425  $668 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
LIABILITIES
        
Current liabilities
        
Accounts payable
 $603  $47,494 
Other payables and accrued liabilities
  5,000   15,000 
Amount due to a related party
  18,413   116,095 
         
TOTAL LIABILITIES
  24,016   178,589 
         
STOCKHOLDERS’ DEFICIT        
         
Preferred stock: par value of $0.001 per share
        
Authorized: 10,000,000 shares at September 30, 2012 and December 31, 2011
        
Issued and outstanding: None at September 30, 2012 and December 31, 2011
  -   - 
Common stock: par value of $0.001 per share
        
Authorized: 250,000,000 shares at September 30, 2012 and December 31, 2011        
Issued and outstanding: 20,006,402 shares at September 30, 2012 and December 31, 2011
        
   20,006   20,006 
Additional paid-in-capital
  431,025   431,025 
Accumulated deficit
  (473,622)  (628,952)
         
TOTAL STOCKHOLDERS’ DEFICIT
  (22,591)  (177,921)
         
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
 $1,425  $668 
  March 31,  December 31, 
  2013  2012 
  (Unaudited)     
ASSETS        
Current assets        
Cash and cash equivalents  $-   $- 
         
TOTAL CURRENT ASSETS / TOTAL ASSETS $-  $- 
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
         
LIABILITIES        
Current liabilities        
Accounts payable $179  $179 
Accrued liabilities  22,059   17,500 
Amount due to a related party  25,145   25,145 
         
TOTAL CURRENT LIABILITIES / TOTAL LIABILITIES  47,383   42,824 
         
STOCKHOLDERS’ DEFICIT        
Preferred stock: par value of $0.001 per share        
Authorized: 10,000,000 shares at March 31, 2013 and December 31, 2012        
Issued and outstanding: 0 shares at March 31, 2013 and December 31, 2012  -   - 
Common stock: par value of $0.001 per share        
Authorized: 250,000,000 shares at March 31, 2013 and December 31, 2012        
Issued and outstanding: 20,006,402 shares at March 31, 2013 and December 31, 2012
  20,006   20,006 
Additional paid-in-capital  609,614   609,614 
Accumulated deficit  (677,003)  (672,444)
         
TOTAL STOCKOLDERS’ DEFICIT  (47,383)  (42,824)
         
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $-  $- 
 
See Notes to the Financial Statements

 
 
41
 

Green Planet Bioengineering Co., Ltd.
Statements of Income
(Unaudited)
(Stated in US Dollars)
Green Planet Bioengineering Co., Ltd.
  Three months ended  Nine months ended
  September 30,  September 30, 
  2012  2011  2012  2011 
             
Administrative expenses $(6,821) $(620) $(23,259) $(13,334)
Gain from extinguishment of debt  -   -   178,589   - 
                 
Income (loss) before taxes  (6,821)  (620)  155,330   (13,334)
Provision for income taxes  -   -   -   - 
                 
Net income (loss) $(6,821) $(620) $155,330  $(13,334)
                 
Earnings per share                
-Basic $0.00  $0.00   0.01  $0.00 
-Diluted $0.00  $0.00   0.01  $0.00 
                 
Weighted average number of shares outstanding                
-Basic  20,006,402   20,006,402   20,006,402   20,006,402 
-Diluted  20,159,001   20,159,001   20,159,001   20,159,001 
Statements of Income
(Unaudited)
(Stated in US Dollars)
  Three months ended March 31, 
  2013  2012 
      As Restated 
Administrative expenses
 $(4,559) $(6,959)
         
Loss before income taxes  (4,559)  (6,959)
Provision for income taxes  -   - 
         
Net loss  (4,559)  (6,959)
         
Earnings per share        
-Basic and diluted $0.00  $0.00 
         
Weighted average number of shares outstanding        
-Basic and diluted  20,006,402   20,006,402 
 
See Notes to the Financial Statements
 
 
52
 

Green Planet Bioengineering Co., Ltd.
Statements of Cash Flows
(Unaudited)
Green Planet Bioengineering Co., Ltd.
Statements of Cash Flows
(Unaudited)
(Stated in US Dollars)
 
 Nine months ended 
 September 30,  Three months ended March 31, 
 2012  2011  2013  2012 
          As Restated  
Cash flows from operating activities              
Net income (loss) $155,330  $(13,334)
Adjustments to reconcile net income (loss) to net cash used by operating activities:        
Gain from extinguishment of debt  (178,589)  - 
Net loss $(4,559) $(6,959)
Changes in operating assets and liabilities:                
Prepaid expenses  (1,425)  - 
Accounts payable  603   -   -   308 
Other payables and accrued liabilities  5,000   - 
Amount due to a related party  18,413   13,334 
      
Net cash flows used by operating activities  (668)  - 
Accrued liabilities  4,559   5,983 
Net cash flows used in operating activities  -   (668)
              
Cash flows from investing activities  -   -   -   - 
              
Cash flows from financing activities  -   -   -   - 
              
Net decrease in cash  (668)  - 
Net decrease in cash and cash equivalents  -   (668
)
Cash and cash equivalents – beginning of period  668   668   -   668 
              
Cash and cash equivalents – end of period $-  $668  $-  $- 
              
Supplemental disclosures for cash flow information:                
Cash paid for interest $-  $-  $-  $- 
Cash paid for income taxes $-  $-  $-  $- 
 
See Notes to the Financial Statements
 
 
63
 
 
Green Planet Bioengineering Co., Ltd
Notes to the Financial Statements
(Unaudited)
1.Organization
Green Planet Bioengineering Co., Ltd.
Notes to the Financial Statements
(Unaudited)

1. Organization
Mondo Acquisition II, Inc. was incorporated in the State of Delaware on October 30, 2006 and changed the name to Green Planet Bioengineering Co., Ltd. (“Company”) on October 2, 2008. In October 2008, the Company acquired Elevated Throne Overseas Ltd, incorporated in British Virgin Islands, and its subsidiaries which was subsequently divested to One Bio, Corp (“ONE”) on April 14, 2010.

In March 2012, the Company reported that ONE has sold its entire stockholding in the Company tobecame a subsidiary of Global Fund Holdings Corp. an Ontario, Canada corporation which became the new majority stockholder.corporation.

2. Summary of significant accounting policies

Basis of Presentation
The accompanying unaudited financial statements of the Companyand related notes have been prepared in accordance with accounting principles generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial statements and are unaudited; however,with the rules and regulations under Regulation S-X of the Securities and Exchange Commission for Form 10-Q. Accordingly, they containdo not include all normal recurring accrualsof the information and adjustments that, infootnotes required by U.S. GAAP for complete financial statements presentation. In the opinion of management, areall adjustments (consisting of normal recurring accruals) considered necessary to present fairly the Company’s financial position, as of the period reporting date, and the results of its operations and cash flows for interim financial statements have been included. These financial statements should be read in conjunction with the reporting period end. The resultsfinancial statements of operationsthe Company together with the Company’s management discussion and analysis in Item 2 of this report and in the Company’s Form 10-K for the reporting period endyear ended December 31, 2012. Interim results are not necessarily indicative of the results to be expected for future quarters or thea full fiscal year.

Use of estimates
In preparing the financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses for the periods reported. Actual results could differ from those estimates.

Cash and cash equivalents
Cash and cash equivalents include all cash, deposits in banks and other highly liquid investments with initial maturities of three months or less to be cash equivalents.

Earnings per share
Earnings (loss) per common share is reported in accordance with ASC Topic 260 “Earnings per Share” which requires dual presentation of basic earnings per share (“EPS”) and diluted EPS on the face of all statements of earnings for all entities with complex capital structures.  Diluted EPS reflects the potential dilution that could occur from common shares issuable through the exercise or conversion of stock options, restricted stock awards, warrants and convertible securities. In certain circumstances, the conversion of these options, warrants and convertible securities are excluded from diluted EPS if the effect of such inclusion would be anti-dilutive.

Income Taxes
The Company accounts for income taxes in accordance with FASB ASC Topic 740 “Income Taxes” under which deferred tax assets and liabilities are determined based on temporary differences between accounting and tax bases of assets and liabilities and net operating loss and credit carry forwards, using enacted tax rates in effect for the year in which the differences are expected to reverse.  Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized.  A provision for income tax expense is recognized for income taxes payable for the current period, plus the net changes in deferred tax amounts

In accordance with FASB ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes”, the Company adopted a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This interpretation also provides guidance on de-recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods and income tax disclosures.

The Company’s policy is to classify income tax assessments, if any, for interest in interest expense and for penalties in administrative expenses. Any interest and penalties associated with an assessment are expensed in the year that a notice is received.
4

Recent Changes in Accounting PronouncementsStandards
Management does not believe that any of the recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Reclassifications
Certain amounts for prior periods have been reclassified to conform to current period’s financial statement presentation. See Note 6.

3. Going Concernconcern

The financial statements have been prepared assuming that the Company will continue as a going concern. The Company is currently a public reorganized corporation and has no current business activity. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
7

4. Gain from extinguishment of debt

According to the terms of the Stock Purchase Agreement dated March 2, 2012 pertaining to divestment of the Company by ONE, the prior period total liabilities of $178,589 was assumed by ONE and, as a result, is no longer payable by the Company.  Accordingly, the amount has been recorded as a gain from extinguishment of debt.

5. Preferred stock / Common stock

Preferred stock
The Company is authorized under its Articles of Incorporation to issue 10 million shares of preferred stock with a par value of $0.001 per share. Each share of the Company’s preferred stock provides the holder with the right to vote 1,000 votes on all matters submitted to a vote of the stockholders of the Company and is convertible into 1,000 shares of the Company’s common stock. The preferred stock is non-participating and carries no dividend.

Common stock
The Company is authorized to issue 250 million shares of common stock with a par value of $0.001 per share. During the three months ended September 30, 2012,March 31, 2013, the Company did not issue any shares of common stock or warrants.

6.5. Stock-based compensation

There waswere no non-cash stock-based compensation recognized for the three and nine months ended September 30, 2012March 31, 2013 and 2011.2012.

There was no warrantswarrant activity during the ninethree months ended September 30, 2012.March 31, 2013. See table below chart referencingfor outstanding warrants as of September 30, 2012:March 31, 2013:
 
      
Average
  Weighted-
Weighted-
Remaining
Exercise
  
Average
Aggregate
Contractual
Intrinsic		 
  Shares  Price  Term (in years)  Value 
             
Outstanding at January 1, 2012  152,599  $0.001   1.8  $- 
Issued  -   -   -   - 
Exercised  -   -   -   - 
Forfeited/cancelled  -   -   -   - 
                
Outstanding at September 30, 2012  152,599  $0.001   1.0  $- 
             
Exercisable at September 30, 2012  152,599  $0.001   1.0  $- 

The following information applies to warrants outstanding and exercisable at September 30, 2012:
 
   Warrants Outstanding Warrants Exercisable
      
     Weighted-      
     Average Weighted-   Weighted-
     Remaining Average   Average
     Contractual Exercise   Exercise
 Exercise price Shares Term (in years) Price Shares Price
            
 $            0.001 152,599 1.0 $            0.001 152,599 $            0.001

   Shares   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Term
(in years) 
   
Aggregate
Intrinsic
Value 
 
                 
Outstanding at January 1, 2013  152,599  $0.001   0.80  $- 
Issued  -   -   -   - 
Exercised  -   -   -   - 
Forfeited/cancelled  -   -   -   - 
                 
Outstanding at March 31, 2013  152,599  $0.001   0.55  $- 
                 
Exercisable at March 31, 2013  152,599  $0.001   0.55  $- 
The fair value of the above warrants at the date of grant in October 2008 was determined using the Black-Scholes valuation model with the following assumptions: risk-free interest rate of 3.61%, volatility of 60%, zero expected dividends and expected life of 5 years.

 
85
 
 
The following information applies to warrants outstanding and exercisable as of  March 31, 2013:
     Warrants Outstanding   Warrants Exercisable 
Exercise price   Shares   
Weighted-
Average
Remaining
Contractual
Term
(in years) 
   Weighted-
Average
Exercise
Price		   Shares  Weighted-
Average
Exercise
Price		 
$0.001   152,599   0.55  $0.001   152,599  $0.001 
6.  Restatement

During March 2012, the Company became a subsidiary of Global Fund Holdings, Corp.  In connection with this transaction, the balance that was recorded on the books as loans from the original parent company or its subsidiaries was forgiven.  As a result, the Company recorded this as a gain on debt extinguishment of $178,589 in March 2012.

During the fourth quarter of 2012, the Company subsequently reclassified this gain as a capital contribution  and has updated the Statement of Operations for the three months ended March 31, 2012 and the related Statement of Cash Flows as of March 31, 2012 to reflect this reclassification as follows:

Statement of Operations – For the Three Months Ended March 31, 2012
  As Originally
Reported		  As 
Restated		 
       
Administrative expenses $(6.959) $(6,959)
Gain from extinguishment of debt  178,589   - 
         
Income (loss) before income taxes  171,630   (6,959)
         
Statement of Cash Flows for the Three Months Ended March 31, 2012        
         
Net income (loss) $171,630  $ 
(6,959
)
Adjustments to reconcile net income to net cash used by operating activities:        
Gain from extinguishment of debt  (178,589)  - 
Changes in operating assets and liabilities:        
Accounts payable  308   308 
Accrued liabilities  5,983   5,983 
         
Net cash flows used in operating activities $(668) $(668)
6

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

General Overview

The Company operates as a public reorganized corporation with the business purpose to acquire or merge with an existing business operation.

Results of Operations and Financial Condition for the three months and nine months ended September 30, 2012,March 31, 2013, as compared to the three months and nine months ended September 30, 2011March 31, 2012

The Company had no active business operations for the three monthsperiods ended March 31, 2013 and nine months ended September 30, 2012 and September 30, 2011.March 31, 2012. Expenses consist of accounting, legal and filing fees. On March 2, 2012, the Company was divested by our former majority stockholder, One Bio, Corp (“ONE”) and according to the terms of the Stock Purchase Agreement executed between the willing parties, all the debts of the Company as of the closing date were assumed by ONE. As a result, the Company recorded $178,589 as a gain from extinguishment of debt.

Liquidity and capital resources

The Company had no active business operations for the three months and nine months ended September 30, 2012.March 31, 2013. Accordingly, the Company had no liquidity and capital resources for those periods.the period.

Critical Accounting PoliciesRisk factors

The Company’s critical accounting policies are still being applied despite that the Company has no ongoing business operations.

Significant Estimates

Critical accounting polices include the areas where we have made what we considered to be particularly subjective or complex judgments in making estimates and where these estimates can significantly impact our financial results under different assumptions and conditions.

We prepare our financial statements in conformity with generally accepted accounting principles in the United States of America. As such, we are required to make certain estimates, judgments and assumptions that we believe are reasonable based upon the information available. These estimates, judgments and assumptions affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the periods presented. Actual results could be different than those estimates.
9

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Market Risks

There has been no material change in market risks since our last Annual Report on Form 10-K for the year ended December 31, 2011.2012.
7

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Not Applicable

ITEM 4.CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (“Exchange Act”)(Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q.

Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of the reportingfiscal period end, our disclosure controls and procedures are designed at a reasonable assurance level and are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2012March 31, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.
 
 
108
 

PART IIOTHER INFORMATION

ITEM 1.
ITEM 1.     LEGAL PROCEEDINGS
 
None

ITEM 2.     UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
 
None

ITEM 3.     DEFAULTS UPON SENIOR SECURITIES
ITEM 3.DEFAULTS UPON SENIOR SECURITIES
 
None

ITEM 4.     RESERVED
ITEM 4.RESERVED

ITEM 5.     OTHER INFORMATION

ITEM 5.OTHER INFORMATION
None

ITEM 6.EXHIBITS
EXHIBITS
31
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of theSarbanes-Oxley Act of 2002
32
Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section1350

31         Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32         Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 350


 
119
 

SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned; thereunto duly authorized this 14th20th day of November, 2012.May, 2013.
 
 GREEN PLANET BIOENGINEERING CO., LTD. 
    
Date: November 14, 2012May 20, 2013By:/s/ Jordan Weingarten 
  Jordan WeingartenPresident and Chief Financial Officer
(Principal Executive Officer and
Principal Financial Officer)
 

10
12